Guardant Health Price To Earning vs. Net Income
| GH Stock | USD 103.10 3.28 3.08% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.44 | 0.6446 |
|
|
For Guardant Health profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Guardant Health to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Guardant Health utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Guardant Health's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Guardant Health over time as well as its relative position and ranking within its peers.
Guardant Health's Revenue Breakdown by Earning Segment
Check out Risk vs Return Analysis.
Guardant Health Revenue Breakdown by Earning Segment
By analyzing Guardant Health's earnings estimates, investors can diagnose different trends across Guardant Health's analyst sentiment over time as well as compare current estimates against different timeframes.
Is there potential for Health Care Providers & Services market expansion? Will Guardant introduce new products? Factors like these will boost the valuation of Guardant Health. Market participants price Guardant higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.22) | Revenue Per Share | Quarterly Revenue Growth 0.385 | Return On Assets | Return On Equity |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Guardant Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Guardant Health Net Income vs. Price To Earning Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Guardant Health's current stock value. Our valuation model uses many indicators to compare Guardant Health value to that of its competitors to determine the firm's financial worth. Guardant Health is rated below average in price to earning category among its peers. It is rated below average in net income category among its peers . The last year's value of Net Loss was reported at (416.28 Million). The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Guardant Health's earnings, one of the primary drivers of an investment's value.Guardant Health's Earnings Breakdown by Geography
Guardant Net Income vs. Price To Earning
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Guardant Health |
| = | (12.01) X |
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Guardant Health |
| = | (416.28 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Guardant Net Income Comparison
Guardant Health is currently under evaluation in net income category among its peers.
Guardant Health Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Guardant Health, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Guardant Health will eventually generate negative long term returns. The profitability progress is the general direction of Guardant Health's change in net profit over the period of time. It can combine multiple indicators of Guardant Health, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -4.9 M | -5.1 M | |
| Net Interest Income | 58.8 M | 61.7 M | |
| Interest Income | 61.7 M | 64.8 M | |
| Operating Income | -437.2 M | -459.1 M | |
| Net Loss | -392.7 M | -412.4 M | |
| Income Before Tax | -417.5 M | -438.4 M | |
| Total Other Income Expense Net | 19.7 M | 20.7 M | |
| Net Loss | -589.1 M | -559.7 M | |
| Net Loss | -416.3 M | -437.1 M | |
| Income Tax Expense | -1.3 M | -1.2 M | |
| Non Operating Income Net Other | -95.8 M | -91.1 M | |
| Change To Netincome | 119.9 M | 70.3 M | |
| Net Loss | (3.32) | (3.49) | |
| Income Quality | 0.44 | 0.69 | |
| Net Income Per E B T | 1.00 | 1.12 |
Guardant Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Guardant Health. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Guardant Health position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Guardant Health's important profitability drivers and their relationship over time.
Guardant Health Earnings Estimation Breakdown
The calculation of Guardant Health's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Guardant Health is estimated to be -0.4756 with the future projection ranging from a low of -0.798 to a high of -0.29. Please be aware that this consensus of annual earnings estimates for Guardant Health is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.8 Lowest | Expected EPS | -0.29 Highest |
Guardant Health Earnings Projection Consensus
Suppose the current estimates of Guardant Health's value are higher than the current market price of the Guardant Health stock. In this case, investors may conclude that Guardant Health is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Guardant Health's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2026 | Current EPS (TTM) | |
| 24 | 61.79% | -0.5 | -0.4756 | -3.22 |
Guardant Health Earnings History
Earnings estimate consensus by Guardant Health analysts from Wall Street is used by the market to judge Guardant Health's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we suggest analyzing not only Guardant Health's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Guardant Health Quarterly Gross Profit |
|
Guardant Health Earnings per Share Projection vs Actual
Actual Earning per Share of Guardant Health refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Guardant Health predict the company's earnings will be in the future. The higher the earnings per share of Guardant Health, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Guardant Health Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Guardant Health, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Guardant Health should always be considered in relation to other companies to make a more educated investment decision.Guardant Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Guardant Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2026-02-19 | 2025-12-31 | -0.775 | -0.5 | 0.275 | 35 | ||
2025-10-29 | 2025-09-30 | -0.79 | -0.39 | 0.4 | 50 | ||
2025-07-30 | 2025-06-30 | -0.72 | -0.44 | 0.28 | 38 | ||
2025-06-12 | 2025-03-31 | -0.85 | -0.49 | 0.36 | 42 | ||
2025-02-20 | 2024-12-31 | -0.5038 | -0.62 | -0.1162 | 23 | ||
2024-11-06 | 2024-09-30 | -0.74 | -0.88 | -0.14 | 18 | ||
2024-08-07 | 2024-06-30 | -0.74 | -0.84 | -0.1 | 13 | ||
2024-05-09 | 2024-03-31 | -0.85 | -0.94 | -0.09 | 10 | ||
2024-02-22 | 2023-12-31 | -0.86 | -0.85 | 0.01 | 1 | ||
2023-11-06 | 2023-09-30 | -0.95 | -0.73 | 0.22 | 23 | ||
2023-08-03 | 2023-06-30 | -1.18 | -0.67 | 0.51 | 43 | ||
2023-05-09 | 2023-03-31 | -1.32 | -1.3 | 0.02 | 1 | ||
2023-02-23 | 2022-12-31 | -1.37 | -1.36 | 0.01 | 0 | ||
2022-11-03 | 2022-09-30 | -1.26 | -1.41 | -0.15 | 11 | ||
2022-08-04 | 2022-06-30 | -1.21 | -1.27 | -0.06 | 4 | ||
2022-05-05 | 2022-03-31 | -1.21 | -1.21 | 0.0 | 0 | ||
2022-02-23 | 2021-12-31 | -1.15 | -0.89 | 0.26 | 22 | ||
2021-11-04 | 2021-09-30 | -0.97 | -1.06 | -0.09 | 9 | ||
2021-08-05 | 2021-06-30 | -0.85 | -0.96 | -0.11 | 12 | ||
2021-05-06 | 2021-03-31 | -0.89 | -1.09 | -0.2 | 22 | ||
2021-02-24 | 2020-12-31 | -0.57 | -0.94 | -0.37 | 64 | ||
2020-11-05 | 2020-09-30 | -0.39 | -0.78 | -0.39 | 100 | ||
2020-08-06 | 2020-06-30 | -0.38 | -0.57 | -0.19 | 50 | ||
2020-05-07 | 2020-03-31 | -0.39 | -0.29 | 0.1 | 25 | ||
2020-02-24 | 2019-12-31 | -0.31 | -0.27 | 0.04 | 12 | ||
2019-11-07 | 2019-09-30 | -0.37 | -0.14 | 0.23 | 62 | ||
2019-08-06 | 2019-06-30 | -0.36 | -0.13 | 0.23 | 63 | ||
2019-05-09 | 2019-03-31 | -0.37 | -0.3 | 0.07 | 18 | ||
2019-03-12 | 2018-12-31 | -0.35 | -0.3 | 0.05 | 14 | ||
2018-11-19 | 2018-09-30 | -0.29 | -1.94 | -1.65 | 568 | ||
2018-08-29 | 2018-06-30 | 0 | -0.28 | -0.28 | 0 |
Use Guardant Health in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Guardant Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guardant Health will appreciate offsetting losses from the drop in the long position's value.Guardant Health Pair Trading
Guardant Health Pair Trading Analysis
The ability to find closely correlated positions to Guardant Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Guardant Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Guardant Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Guardant Health to buy it.
The correlation of Guardant Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Guardant Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Guardant Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Guardant Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Guardant Health position
In addition to having Guardant Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Sovereign ETFs Thematic Idea Now
Broad Sovereign ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Sovereign ETFs theme has 14 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Sovereign ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
To fully project Guardant Health's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Guardant Health at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Guardant Health's income statement, its balance sheet, and the statement of cash flows.